Publications by authors named "Kelly Zullo"

Claim this Profile
L
LINGO3 regulates mucosal tissue regeneration and promotes TFF2 dependent recovery from colitis.
Kelly M Zullo, Bonnie Douglas, Nicole M Maloney, Yingbiao Ji, Yun Wei

Scand J Gastroenterol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NPM-ALK-Induced Reprogramming of Mature TCR-Stimulated T Cells Results in Dedifferentiation and Malignant Transformation.
Jan M Pawlicki, David L Cookmeyer, Damian Maseda, John K Everett, Fang Wei, Kelly M Zullo

Cancer Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular context of IL-33 expression dictates impact on anti-helminth immunity.
Li-Yin Hung, Yukinori Tanaka, Karl Herbine, Christopher Pastore, Brenal Singh, Kelly Zullo

Sci Immunol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATM inhibition overcomes resistance to histone deacetylase inhibitor due to p21 induction and cell cycle arrest.
Luigi Scotto, Xavier J Serrano, Kelly Zullo, Cristina Kinahan, Changchun Deng

Oncotarget· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TFF3 interacts with LINGO2 to regulate EGFR activation for protection against colitis and gastrointestinal helminths.
Nicole Maloney Belle, Yingbiao Ji, Karl Herbine, Yun Wei, JoonHyung Park, Kelly Zullo

Nat Commun· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Group 2 Innate Lymphoid Cells (ILC2): Type 2 Immunity and Helminth Immunity.
De'Broski R Herbert, Bonnie Douglas, Kelly Zullo

Int J Mol Sci· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of Acquired Drug Resistance to the HDAC6 Selective Inhibitor Ricolinostat Reveals Rational Drug-Drug Combination with Ibrutinib.
Jennifer E Amengual, Sathyen A Prabhu, Maximilian Lombardo, Kelly Zullo, Paul M Johannet

Clin Cancer Res· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel kinesin spindle protein (KSP) inhibitor SB-743921 exhibits marked activity in in vivo and in vitro models of aggressive large B-cell lymphoma.
Danielle Bongero, Luca Paoluzzi, Enrica Marchi, Kelly M Zullo, Roberto Neisa

Leuk Lymphoma· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The addition of granulocyte-colony stimulating factor shifts the dose limiting toxicity and markedly increases the maximum tolerated dose and activity of the kinesin spindle protein inhibitor SB-743921 in patients with relapsed or refractory lymphoma: results of an international, multicenter phase I/II study.
Owen A O'Connor, John Gerecitano, Henrik Van Deventer, John Hainsworth, Kelly M Zullo

Leuk Lymphoma· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Targeting of Protein Degradation Pathways with the Selective HDAC6 Inhibitor ACY-1215 and Bortezomib Is Synergistic in Lymphoma.
Jennifer E Amengual, Paul Johannet, Maximilian Lombardo, Kelly Zullo, Daniela Hoehn

Clin Cancer Res· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T-cell lymphoma.
Enrica Marchi, Kelly M Zullo, Jennifer E Amengual, Matko Kalac, Danielle Bongero

Br J Haematol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aurora A Kinase Inhibition Selectively Synergizes with Histone Deacetylase Inhibitor through Cytokinesis Failure in T-cell Lymphoma.
Kelly M Zullo, Yige Guo, Laurence Cooke, Xavier Jirau-Serrano, Michael Mangone

Clin Cancer Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical pharmacologic evaluation of pralatrexate and romidepsin confirms potent synergy of the combination in a murine model of human T-cell lymphoma.
Salvia Jain, Xavier Jirau-Serrano, Kelly M Zullo, Luigi Scotto, Carmine F Palermo

Clin Cancer Res· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pralatrexate pharmacology and clinical development.
Enrica Marchi, Michael Mangone, Kelly Zullo, Owen A O'Connor

Clin Cancer Res· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Murine models in mantle cell lymphoma.
Kelly Zullo, Jennifer E Amengual, Owen A O'Connor, Luigi Scotto

Best Pract Res Clin Haematol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis